Huntington's Disease

Study Unveils Rare Cannabinoid As Promising Hope For Alzheimer's, Parkinson's & Huntington's Treatment

DEA Sued By Rhode Island Lab Over 'Foot Dragging' On Marijuana Pharmaceutical Licensing, Here's What We Know So Far

Stealth Bio's SBT-272 Shows Encouraging Action In Huntington's Disease Animal Model

DEA Sued By Rhode Island Lab Over 'Foot Dragging' On Marijuana Pharmaceutical Licensing, Here's What We Know So Far

Stealth Bio's SBT-272 Shows Encouraging Action In Huntington's Disease Animal Model

Annexon's Interim Mid-Stage Results On Huntington's Disease Candidate Fails To Cheer

UniQure Shares Fall After Clinical Update From Huntington's Disease Gene Therapy Trial

Annexon's Interim Mid-Stage Results On Huntington's Disease Candidate Fails To Cheer

UniQure Shares Fall After Clinical Update From Huntington's Disease Gene Therapy Trial

Neurocrine's Ingrezza Meets Primary Goal In Phase 3 Study In Patients With Involuntary Muscle Movement

Roche's Spark Therapeutics, NeuExcell Join Forces To Develop Huntington's Disease Gene Therapy

Huntington's Disease Recent News

DSMB Recommends UniQure To Continue Huntington's Gene Therapy Trial Unchanged

Voyager Therapeutics' Stock Jumps As FDA Lifts Clinical Hold For Huntington's Disease Gene Therapy

Wave Life Sciences Stock Plunges After Antisense Oligonucleotide Candidates Disappoint In Huntington's Disease Study

Wave Life Sciences Ltd's (NASDAQ: WVE) closely-watched

Ionis Pharma Stock Is Trading Lower After Roche Drops Huntington's Disease Trial With Tominersen

Roche Holdings AG (OTCMKTS: RHHBY) has halted dosing for its Phase 3 study of tominersen, an ant

No Safety Concerns Observed In Uniqure's Early-Stage Huntington's Gene Therapy Study, DSMB Says

Janney: Buy The Dip In Uniqure